![Ιδρυματικό Αποθετήριο [SANDBOX]](images/dias.logo.png "Ιδρυματικό Αποθετήριο [SANDBOX]"){kind=logo}
Ιδρυματικό Αποθετήριο [SANDBOX]
Πολυτεχνείο Κρήτης
Πολυτεχνείο Κρήτης
EN
|
EL
| URI: | http://purl.tuc.gr/dl/dias/C2604C02-EA37-4048-84BF-8E569E6DA412 | ||
| Έτος | 2011 | ||
| Τύπος | Πλήρης Δημοσίευση σε Συνέδριο | ||
| Άδεια Χρήσης |
|
||
| Βιβλιογραφική Αναφορά | M. G. Kounelakis, M. E. Zervakis, G. C. Giakos, X. Kotsiakis ,"The role of the glycolysis-related genes in brain gliomas treatment design ," in 2011 5th European Conf. of the Intern.Federation for Med. and Biological Eng. ,pp. 377-380.doi:10.1007/978-3-642-23508-5_98 https://doi.org/10.1007/978-3-642-23508-5_98 | ||
| Εμφανίζεται στις Συλλογές |
The aim of this study is to reveal the significance of glycolysis-related genes in the design of new brain gliomas treatment protocols. Towards this direction a feature selection and classification method, embedding the Relief-F filter criterion under a Support Vector Machines (SVM) classifier, has been introduced focusing on the identification of significant genetic alterations related to glycolysis. In particular a genomic (Microarray Expression) dataset, consisting of 14 glioma patients has been used for the statistical analysis. The results have demonstrated that a specific group of gene markers (HK, PGI, PFK, ALDO, GAPDH, PGK, PGM, ENO, PK, LDH, PDH and MDH) directly related to cell glycolysis, have a great impact on the discrimination of different grades of gliomas malignancy (AUROC of 0.98), thus leading to the conclusion that these markers could establish the foundations for new therapeutic approaches.
Copyright © DIAS 2013
